Delivery Order SPE2DB20D3103-SPE2DB25FN7M9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $8,205.18 firm fixed price delivery order for Zepbound 15 mg/0.5 mL pen injectors, with an ultimate completion date of September 9, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role in supplying pharmaceutical products to federal medical procurement...
- The Defense Logistics Agency awarded a $5,341.80 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with a completion date of September 9, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 8, 2025, with the place of performance in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader contract vehicle with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens valued at $30,993.63, with a firm fixed price structure and no set-aside designation. The award was executed on June 5, 2025, with an ultimate completion date of June 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a $17,544.13 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This is a firm fixed price contract with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $15,401.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on June 3, 2025, with an ultimate completion date of June 4, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. The place of performance...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $17,749.40 for Zepbound 2.5 mg/0.5 ml pens with a completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $5,338.06 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN7M9Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,664.58 firm fixed price delivery order for Zepbound 5 mg/0.5 ml pens on May 8, 2025, with completion scheduled for May 9, 2025. This competitively awarded, non-set-aside contract represents a single-line item pharmaceutical delivery to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to military healthcare programs and other federal healthcare systems worldwide. The Zepbound delivery represents one of numerous pharmaceutical orders executed under this strategic contract vehicle, which positions AmerisourceBergen as a critical vendor for the Defense Health Agency and other federal health system customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 5/8/25 |